Page last updated: 2024-10-18

dihydroxyphenylalanine and Orbital Neoplasms

dihydroxyphenylalanine has been researched along with Orbital Neoplasms in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Orbital Neoplasms: Neoplasms of the bony orbit and contents except the eyeball.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruiz, JB1
Orré, M1
Cazeau, AL1
Henriques de Figueiredo, B1
Godbert, Y1

Other Studies

1 other study available for dihydroxyphenylalanine and Orbital Neoplasms

ArticleYear
18F-DOPA PET/CT in Orbital Metastasis From Medullary Thyroid Carcinoma.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:6

    Topics: Adult; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes

2016